Advertisement
Screener

VANDA PHARMACEUTICALS INC. (VNDA) Payments for Restructuring

2.8 / 5 stars · 68/120 Roast Me

VANDA PHARMACEUTICALS INC. Payments for Restructuring

VANDA PHARMACEUTICALS INC. (VNDA) reported Payments for Restructuring of $384.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-25.

Discontinued › Cash Flow › Financing Activities

us-gaap:PaymentsForRestructuring · last filed 2014-02-25

  • VANDA PHARMACEUTICALS INC. payments for restructuring for the quarter ending 2013-12-31 was $0.00.
  • VANDA PHARMACEUTICALS INC. payments for restructuring for the quarter ending 2013-09-30 was $0.00.
  • VANDA PHARMACEUTICALS INC. payments for restructuring for fiscal 2013 was $384.00K, a 74.52% decline from fiscal 2012.
  • VANDA PHARMACEUTICALS INC. payments for restructuring for fiscal 2012 was $1.51M.
Period endPayments for Restructuring 3 monthPayments for Restructuring 6 monthPayments for Restructuring 9 monthPayments for Restructuring 12 month
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$0.00
derived: sum of 2 quarters · filed 2014-02-25
$384.00K
10-K · filed 2014-02-25
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$384.00K
10-Q · filed 2013-11-08
2013-06-30$384.00K
10-Q · filed 2013-07-31
2012-12-31$1.51M
10-K · filed 2014-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Evommune, Inc. (EVMN)United States$0.320B-5.10
Upstream Bio, Inc. (UPB)United States$0.284B-2.42